Calidi Biotherapeutics, Inc. Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations
Calidi Biotherapeutics, Inc. (CLDI) reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations of $1.58 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-15.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations · last filed 2024-03-15
- Calidi Biotherapeutics, Inc. cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect disposal group including discontinued operations for fiscal 2023 was $1.58M.
- Calidi Biotherapeutics, Inc. cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect disposal group including discontinued operations for fiscal 2022 was -$1.65M.
| Period end | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations 9 month | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations 12 month |
|---|---|---|
| 2023-12-31 | $1.58M 10-K · filed 2024-03-15 | |
| 2023-09-30 | $9.78M 10-Q · filed 2023-11-14 | |
| 2022-12-31 | -$1.65M 10-K · filed 2024-03-15 | |
| 2022-09-30 | -$1.94M 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |